Comparison of binding platforms yields insights into receptor binding differences between Shiga toxins 1 and 2

Por Flagler, Michael J., Mahajan, Sujit S., Kulkarni, Ashish A., Iyer, Suri S., Weiss, Alison A.
Publicado em 2010

Glycan Encapsulated Gold Nanoparticles Selectively Inhibit Shiga Toxins 1 and 2

Por Kulkarni, Ashish A., Fuller-Schaefer, Cynthia, Korman, Henry, Weiss, Alison A., Iyer, Suri S.
Publicado em 2010

Amphiphilic Beads as Depots for Sustained Drug Release Integrated into Fibrillar Scaffolds

Por Gaharwar, Akhilesh K., Mihaila, Silvia M., Kulkarni, Ashish A., Patel, Alpesh, Di Luca, Andrea, Reis, Rui L., Gomes, Manuela E., van Blitterswijk, Clemens, Moroni, Lorenzo, Khademhosseini, Ali
Publicado em 2014

Supramolecular nanoparticles that target phosphatidylinositol-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy

Por Kulkarni, Ashish A., Roy, Bhaskar, Rao, Poornima S., Wyant, Gregory A., Mahmoud, Ayaat, Ramachandran, Madhumitha, Sengupta, Poulomi, Goldman, Aaron, Kotamraju, Venkata Ramana, Basu, Sudipta, Mashelkar, Raghunath A, Ruoslahti, Erkki, Dinulescu, Daniela M., Sengupta, Shiladitya
Publicado em 2013